266 related articles for article (PubMed ID: 15767188)
1. A case of male breast cancer in association with bicalutamide-induced gynaecomastia.
Chianakwalam CI; McCahy P; Griffiths NJ
Breast; 2005 Apr; 14(2):163-4. PubMed ID: 15767188
[No Abstract] [Full Text] [Related]
2. The role of tamoxifen in reducing bicalutamide-induced gynaecomastia and breast pain.
Nuttall MC; Harris JP; Dawkins GP
BJU Int; 2007 Feb; 99(2):243-4. PubMed ID: 17313420
[No Abstract] [Full Text] [Related]
3. [Gynecomastia as a complication of hormonotherapy for prostate cancer: effect of prophylactic breast irradiation].
Abdah-Bortnyak R; Bernstein Z; Ramon N; Zalman D; Shnaider J; Kuten A
Harefuah; 2007 Feb; 146(2):126-8, 164-5. PubMed ID: 17352282
[TBL] [Abstract][Full Text] [Related]
4. Editorial comment on: Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.
Van Poppel H
Eur Urol; 2007 Jul; 52(1):115. PubMed ID: 17270341
[No Abstract] [Full Text] [Related]
5. Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer.
Van Poppel H; Tyrrell CJ; Haustermans K; Cangh PV; Keuppens F; Colombeau P; Morris T; Garside L
Eur Urol; 2005 May; 47(5):587-92. PubMed ID: 15826748
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.
Fradet Y; Egerdie B; Andersen M; Tammela TL; Nachabe M; Armstrong J; Morris T; Navani S
Eur Urol; 2007 Jul; 52(1):106-14. PubMed ID: 17270340
[TBL] [Abstract][Full Text] [Related]
7. [The use of Casodex (bicalutamide) in the treatment of disseminated prostatic cancer].
Sivko AV; Prokhorov AV
Urol Nefrol (Mosk); 1997; (3):49-52. PubMed ID: 9245060
[No Abstract] [Full Text] [Related]
8. Bicalutamide-induced gynaecomastia: do we have the answer?
Di Lorenzo G; Autorino R
Eur Urol; 2007 Jul; 52(1):5-8. PubMed ID: 17258386
[No Abstract] [Full Text] [Related]
9. Images in clinical medicine. Gynecomastia induced by prostate-cancer treatment.
Michalopoulos NV; Keshtgar MR
N Engl J Med; 2012 Oct; 367(15):1449. PubMed ID: 23050528
[No Abstract] [Full Text] [Related]
10. Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.
Di Lorenzo G; Perdonà S; De Placido S; D'Armiento M; Gallo A; Damiano R; Pingitore D; Gallo L; De Sio M; Autorino R
J Urol; 2005 Dec; 174(6):2197-203. PubMed ID: 16280763
[TBL] [Abstract][Full Text] [Related]
11. Fulminant hepatic failure associated with bicalutamide.
Dawson LA; Chow E; Morton G
Urology; 1997 Feb; 49(2):283-4. PubMed ID: 9037299
[TBL] [Abstract][Full Text] [Related]
12. Treatment of bicalutamide-induced gynecomastia with breast-reduction surgery in prostate cancer.
Nakabayashi M; Bartlett RA; Oh WK
J Clin Oncol; 2006 Jun; 24(18):2958-9. PubMed ID: 16782932
[No Abstract] [Full Text] [Related]
13. Treatment of bicalutamide-induced breast events.
Sieber PR
Expert Rev Anticancer Ther; 2007 Dec; 7(12):1773-9. PubMed ID: 18062751
[TBL] [Abstract][Full Text] [Related]
14. Bicalutamide.
Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17458049
[TBL] [Abstract][Full Text] [Related]
15. Photosensitive drug eruption induced by bicalutamide within the UVB action spectrum.
Sasada K; Sakabe J; Tamura A; Kasuya A; Shimauchi T; Ito T; Hirakawa S; Tokura Y
Eur J Dermatol; 2012; 22(3):402-3. PubMed ID: 22503957
[No Abstract] [Full Text] [Related]
16. Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia.
Tyrrell CJ; Payne H; Tammela TL; Bakke A; Lodding P; Goedhals L; Van Erps P; Boon T; Van De Beek C; Andersson SO; Morris T; Carroll K
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):476-83. PubMed ID: 15380582
[TBL] [Abstract][Full Text] [Related]
17. An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients.
Bedognetti D; Rubagotti A; Conti G; Francesca F; De Cobelli O; Canclini L; Gallucci M; Aragona F; Di Tonno P; Cortellini P; Martorana G; Lapini A; Boccardo F
Eur Urol; 2010 Feb; 57(2):238-45. PubMed ID: 19481335
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial.
Perdonà S; Autorino R; De Placido S; D'Armiento M; Gallo A; Damiano R; Pingitore D; Gallo L; De Sio M; Bianco AR; Di Lorenzo G
Lancet Oncol; 2005 May; 6(5):295-300. PubMed ID: 15863377
[TBL] [Abstract][Full Text] [Related]
19. Interstitial pneumonitis following bicalutamide treatment for prostate cancer.
McCaffrey JA; Scher HI
J Urol; 1998 Jul; 160(1):131. PubMed ID: 9628626
[No Abstract] [Full Text] [Related]
20. Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.
Boccardo F; Rubagotti A; Conti G; Potenzoni D; Manganelli A; Del Monaco D
Cancer Chemother Pharmacol; 2005 Oct; 56(4):415-20. PubMed ID: 15838655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
